BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 38847249)

  • 1. Single-cell and Bulk Transcriptomic Analyses Reveal a Stemness and Circadian Rhythm Disturbance-related Signature Predicting Clinical Outcome and Immunotherapy Response in Hepatocellular Carcinoma.
    Zhu X; Zhang Z; Zhang J; Xiao Y; Wang H; Wang M; Jiang M; Xu Y
    Curr Gene Ther; 2024 Jun; ():. PubMed ID: 38847249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of a stemness-based classifier for prognosis and immunotherapy response of hepatocellular carcinoma based on bioinformatics and machine-learning strategies.
    Chen E; Zou Z; Wang R; Liu J; Peng Z; Gan Z; Lin Z; Liu J
    Front Immunol; 2024; 15():1244392. PubMed ID: 38694506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological Value of Prognostic Signature Based on Cancer Stem Cell Characteristics in Hepatocellular Carcinoma.
    Xu Q; Xu H; Chen S; Huang W
    Front Cell Dev Biol; 2021; 9():710207. PubMed ID: 34409040
    [No Abstract]   [Full Text] [Related]  

  • 4. Integrated analysis revealing a novel stemness-metabolism-related gene signature for predicting prognosis and immunotherapy response in hepatocellular carcinoma.
    Wang Y; Wan X; Du S
    Front Immunol; 2023; 14():1100100. PubMed ID: 37622118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel stemness-hypoxia-related signature for prognostic stratification and immunotherapy response in hepatocellular carcinoma.
    Zhang G; Zhang K; Zhao Y; Yang Q; Lv X
    BMC Cancer; 2022 Oct; 22(1):1103. PubMed ID: 36307751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic clinical phenotypes associated with tumor stemness in the immune microenvironment of T-cell exhaustion for hepatocellular carcinoma.
    Zhang G
    Discov Oncol; 2023 Nov; 14(1):203. PubMed ID: 37957420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction and validation of a novel signature based on epithelial-mesenchymal transition-related genes to predict prognosis and immunotherapy response in hepatocellular carcinoma by comprehensive analysis of the tumor microenvironment.
    Gao B; Wang Y; Lu S
    Funct Integr Genomics; 2022 Dec; 23(1):6. PubMed ID: 36536232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of molecular subtypes based on PANoptosis-related genes and construction of a signature for predicting the prognosis and response to immunotherapy response in hepatocellular carcinoma.
    Zhu J; Huang Q; Peng X; Luo C; Liu Z; Liu D; Yuan H; Yuan R; Cheng X
    Front Immunol; 2023; 14():1218661. PubMed ID: 37662906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stemness analysis in hepatocellular carcinoma identifies an extracellular matrix gene-related signature associated with prognosis and therapy response.
    Chen L; Zhang D; Zheng S; Li X; Gao P
    Front Genet; 2022; 13():959834. PubMed ID: 36110210
    [No Abstract]   [Full Text] [Related]  

  • 10. Deep dissection of stemness-related hierarchies in hepatocellular carcinoma.
    Liang R; Hong W; Zhang Y; Ma D; Li J; Shi Y; Luo Q; Du S; Song G
    J Transl Med; 2023 Sep; 21(1):631. PubMed ID: 37717019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integration of single-cell RNA-seq and bulk RNA-seq to construct liver hepatocellular carcinoma stem cell signatures to explore their impact on patient prognosis and treatment.
    Liu L; Zhang M; Cui N; Liu W; Di G; Wang Y; Xi X; Li H; Shen Z; Gu M; Wang Z; Jiang S; Liu B
    PLoS One; 2024; 19(4):e0298004. PubMed ID: 38635528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen-related genes influence immune cell infiltration and immunotherapy response in Hepatocellular Carcinoma.
    Gao B; Wang Y; Li C; Lu S
    Front Immunol; 2023; 14():1114717. PubMed ID: 36814910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a novel stemness-related prognostic model for neuroblastoma using integrated machine learning and bioinformatics analyses.
    Xia Y; Wang C; Li X; Gao M; Hogg HDJ; Tunthanathip T; Hulsen T; Tian X; Zhao Q
    Transl Pediatr; 2024 Jan; 13(1):91-109. PubMed ID: 38323183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of cellular senescence patterns predicts the prognosis and therapeutic response of hepatocellular carcinoma.
    Tang Y; Guo C; Chen C; Zhang Y
    Front Mol Biosci; 2022; 9():1100285. PubMed ID: 36589233
    [No Abstract]   [Full Text] [Related]  

  • 15. Integration of scRNA-seq and bulk RNA-seq constructs a stemness-related signature for predicting prognosis and immunotherapy responses in hepatocellular carcinoma.
    Wang X; Chen X; Zhao M; Li G; Cai D; Yan F; Fang J
    J Cancer Res Clin Oncol; 2023 Nov; 149(15):13823-13839. PubMed ID: 37535162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overweight/obesity-related transcriptomic signature as a correlate of clinical outcome, immune microenvironment, and treatment response in hepatocellular carcinoma.
    Feng NN; Du XY; Zhang YS; Jiao ZK; Wu XH; Yang BM
    Front Endocrinol (Lausanne); 2022; 13():1061091. PubMed ID: 36714595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a hypoxia-stemness-based prognostic signature in pancreatic adenocarcinoma.
    Tian X; Zheng J; Mou W; Lu G; Chen S; Du J; Zheng Y; Chen S; Shen B; Li J; Wang N
    Front Pharmacol; 2022; 13():939542. PubMed ID: 35935823
    [No Abstract]   [Full Text] [Related]  

  • 18. Non-Apoptotic Programmed Cell Death-Related Gene Signature Correlates With Stemness and Immune Status and Predicts the Responsiveness of Transarterial Chemoembolization in Hepatocellular Carcinoma.
    Zhang G; Fan W; Wang H; Wen J; Tan J; Xue M; Li J
    Front Cell Dev Biol; 2022; 10():844013. PubMed ID: 35573678
    [No Abstract]   [Full Text] [Related]  

  • 19. Development and Validation of a Novel Circadian Rhythm-Related Signature to Predict the Prognosis of the Patients with Hepatocellular Carcinoma.
    Wu Y; Shen C; Wang X; Zhao W; Li Y; He X; Chen Y; Liu J; Wu X; Shen A
    Biomed Res Int; 2022; 2022():4263261. PubMed ID: 35993051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated Machine Learning and Bioinformatic Analyses Constructed a Novel Stemness-Related Classifier to Predict Prognosis and Immunotherapy Responses for Hepatocellular Carcinoma Patients.
    Chen D; Liu J; Zang L; Xiao T; Zhang X; Li Z; Zhu H; Gao W; Yu X
    Int J Biol Sci; 2022; 18(1):360-373. PubMed ID: 34975338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.